Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.

نویسندگان

  • N Franchimont
  • V Putzeys
  • J Collette
  • S Vermeire
  • P Rutgeerts
  • M De Vos
  • A Van Gossum
  • D Franchimont
  • R Fiasse
  • P Pelckmans
  • M Malaise
  • J Belaiche
  • E Louis
چکیده

BACKGROUND Crohn's disease is associated with low bone mineral density and altered bone metabolism. AIM To assess the evolution of bone metabolism in Crohn's disease patients treated with infliximab. METHODS We studied 71 Crohn's disease patients treated for the first time with infliximab for refractory Crohn's disease. Biochemical markers of bone formation (type-I procollagen N-terminal propeptide, bone-specific alkaline phosphatase, osteocalcin) and of bone resorption (C-telopeptide of type-I collagen) were measured in the serum before and 8 weeks after infliximab therapy and compared with values in a matched healthy control group. RESULTS Eight weeks after treatment with infliximab, a normalization of bone markers was observed with a median increase in formation markers of 14-51% according to marker and a lower but significant decrease in resorption marker (median 11%). A clinically relevant increase in bone formation markers was present in 30-61% of patients according to the marker. A clinically relevant decrease in C-telopeptide of type-I collagen was present in 38% of patients. No association was found with any tested demographic or clinical parameter. CONCLUSION Infliximab therapy in Crohn's disease may rapidly influence bone metabolism by acting either on bone formation or bone resorption. This improvement seems to be independent of clinical response to infliximab.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Infliximab and the bone in Crohn's disease.

SIRS, In parallel to their use for Crohn's disease (CD), anti-tumour necrosis factor (TNF) therapies have become a powerful approach for the treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylarthropathy (SpA) and data are becoming available concerning the effects of anti-TNF on bone remodelling. Our paper clearly indicates that infliximab treatment is associated with ...

متن کامل

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

BACKGROUND AND AIMS Treatment with infliximab induces remission in about 70% of patients with steroid refractory Crohn's disease. Because Crohn's disease is considered to be mediated by uncontrolled activation of mucosal T lymphocytes, we hypothesised that infliximab could induce apoptosis of T lymphocytes. METHODS Induction of apoptosis in vivo was studied in 10 patients with therapy refract...

متن کامل

The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.

BACKGROUND AND AIMS A drug interaction between infliximab and azathioprine has previously been reported in Crohn's disease patients: the concentration of the main active thiopurine metabolites, the 6-thioguanine nucleotides (6-TGN), increased 1-3 weeks after the first infliximab infusion by 50% compared to baseline. The aim of this prospective study was to determine the effect of adalimumab on ...

متن کامل

Autoimmune hepatitis during infliximab therapy for Crohn's disease: a case report.

We present the case of a 60-year-old Caucasian male with Crohn's disease treated with infliximab. Within 14 weeks of treatment induction, an asymptomatic acute hepatitis was detected. Elevated autoantibodies and liver biopsy findings supported the diagnosis of autoimmune hepatitis. No competing aetiologies were present. The hepatitis completely responded to infliximab cessation and administrati...

متن کامل

Hidradenitis suppurativa and Crohn's disease: two cases that support an association.

An association between Crohn's disease and hidradenitis suppurativa has been suggested. The presence of Crohn's disease generally precedes the diagnosis of hidradenitis suppurativa. We present two new cases in which hidradenitis lesions developed before Crohn's disease, suggesting an overlap and supporting an association. Furthermore, in one of these cases, treatment with infliximab resulted in...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Alimentary pharmacology & therapeutics

دوره 20 6  شماره 

صفحات  -

تاریخ انتشار 2004